Skip to Content

Join the 'Reversal of Dabigatran' group to help and get support from people like you.

Reversal of Dabigatran News

Drug Combo for Irregular Heartbeat Might Raise Bleeding Risk

Posted 12 days ago by Drugs.com

MONDAY, Nov. 21, 2016 – Because the irregular heartbeat known as atrial fibrillation can trigger stroke-inducing clots, many patients are prescribed a blood thinner. But a new Canadian study suggests that combining one blood thinner, Pradaxa, with certain statin medications could raise the odds for bleeding in these patients. "An increase in the risk of bleeding requiring hospital admission or emergency department visits was seen with lovastatin [Mevacor] and simvastatin [Zocor] compared with the other statins," said study author Tony Antoniou, a pharmacist at St. Michael's Hospital in Toronto. His team tracked outcomes for nearly 46,000 patients ages 65 and older. All had atrial fibrillation and took Pradaxa (dabigatran) to reduce their risk of stroke. Those who also took either lovastatin or simvastatin had a 40 percent higher risk of bleeding than those who took other statins, the ... Read more

Related support groups: Bleeding Disorder, Atrial Fibrillation, Lipitor, Simvastatin, Crestor, Atorvastatin, Pravastatin, Pradaxa, Zocor, Lovastatin, Prevention of Thromboembolism in Atrial Fibrillation, Rosuvastatin, Vytorin, Pravachol, Livalo, Red Yeast Rice, Caduet, Simcor, Lescol, Lescol XL

Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa

Posted 3 Oct 2016 by Drugs.com

MONDAY, Oct. 3, 2016 – The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests. Most patients with the condition take a blood thinner to reduce the risk of stroke. Although these drugs help prevent stroke, they can also cause uncontrollable bleeding, which can be fatal, the researchers said. Two newer drugs – Xarelto (rivaroxaban) and Pradaxa (dabigatran) – are replacing the older drug warfarin, a medication that is notoriously difficult to monitor. Which of these newer drugs is safer, however, hasn't been proven, said the U.S. Food and Drug Administration researchers behind the new study. "There are now several new oral anticoagulants and we don't have a lot of studies that compare one to the other," said Dr. Rita Redberg. A professor of cardiology at the ... Read more

Related support groups: Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Pradaxa, Prevention of Thromboembolism in Atrial Fibrillation, Jantoven, Coagulation Defects and Disorders, Reversal of Dabigatran

Aspirin Often Wrongly Prescribed for Atrial Fibrillation

Posted 20 Jun 2016 by Drugs.com

MONDAY, June 20, 2016 – More than one-third of U.S. patients with the abnormal heartbeat atrial fibrillation who need a blood thinner to prevent strokes aren't getting one, researchers say. About 40 percent of "a-fib" patients deemed at moderate to severe risk of stroke because of age or other conditions are prescribed aspirin alone rather than recommended blood thinners such as Xarelto (rivaroxaban) or warfarin, according to a new study. "Despite clear guideline recommendations that patients at risk for stroke that have atrial fibrillation should be given blood thinners, many of these patients are not prescribed these potentially lifesaving medications," said lead researcher Dr. Jonathan Hsu. He is an assistant professor of medicine, cardiology and cardiac electrophysiology at the University of California, San Diego. Another heart specialist agreed. "Aspirin is not an anticoagulant ... Read more

Related support groups: Aspirin, Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Pradaxa, Excedrin, Eliquis, Prevention of Thromboembolism in Atrial Fibrillation, Aggrenox, Alka-Seltzer, Fiorinal, Rivaroxaban, Excedrin Migraine, Ecotrin, Fiorinal with Codeine, Arthritis Pain, Arthritis Pain Formula, Soma Compound, Apixaban

Women Less Likely to Get Blood Thinner for Irregular Heartbeat

Posted 8 Jun 2016 by Drugs.com

WEDNESDAY, June 8, 2016 – Among people with the common heart rhythm disorder known as atrial fibrillation, women are less likely than men to receive blood-thinning drugs, a new study reveals. Blood thinners are important for people with atrial fibrillation because they help prevent stroke. Atrial fibrillation causes an irregular heartbeat. In people with atrial fibrillation, blood doesn't move from one part of the heart to the other as it should. Instead, the blood can pool and may clot. If a clot travels to the brain, it can cause a stroke. Blood-thinning drugs can help keep clots from forming, according to the U.S. National Heart, Lung, and Blood Institute. For the study, researchers reviewed data from nearly 1,600 people with atrial fibrillation. Among these patients, 55 percent of women were taking blood thinners, compared with 61 percent of men. "The irony is that women have a ... Read more

Related support groups: Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Pradaxa, Eliquis, Prevention of Thromboembolism in Atrial Fibrillation, Rivaroxaban, Apixaban, Arixtra, Fondaparinux, Jantoven, Dabigatran, Edoxaban, Savaysa, Arixtra 7.5 mg/dose, Reversal of Dabigatran, Dicumarol, Arixtra 5 mg/dose, Miradon

Is Daily Blood Thinner Needed for Irregular Heartbeat?

Posted 7 May 2016 by Drugs.com

FRIDAY, May 6, 2016 – A smartphone app might offer an alternative for certain patients with an irregular heartbeat who must take risky blood-thinning medication every day to lower their risk for stroke. New research suggests some people with atrial fibrillation might do just as well by diligently monitoring their pulse, perhaps recording their heartbeat via a smartphone EKG, and only taking such drugs on an as-needed basis. Atrial fibrillation is a serious condition characterized by an abnormal or irregular heart rhythm. Uncontrolled, it can lead to blood clotting and stroke. Blood-thinning drugs, called anticoagulants, are the usual treatment. For years, the blood thinner warfarin (Coumadin) has been the top go-to drug for such patients. "The problem is that long-term use of anticoagulants is associated with an increased risk of bleeding," explained study co-author Dr. Francis ... Read more

Related support groups: Bleeding Disorder, Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Arrhythmia, Pradaxa, Eliquis, Prevention of Thromboembolism in Atrial Fibrillation, Rivaroxaban, Apixaban, Dabigatran, Jantoven, Coagulation Defects and Disorders, Reversal of Dabigatran

Warfarin Can Be Safe, Effective for People With Irregular Heartbeat

Posted 20 Apr 2016 by Drugs.com

WEDNESDAY, April 20, 2016 – Millions of American heart patients take warfarin – for decades a cheap, but often tricky-to-manage mainstay blood thinner. Now, new research shows that when it is well-managed, warfarin treatment appears safe for people with atrial fibrillation, a common heart rhythm disorder. "Well-managed warfarin treatment is a valid alternative in patients with atrial fibrillation who require anticoagulant treatments, with relatively low complication rates and low all-cause [death rates]," concludes a team led by Dr. Fredrik Bjorck of Umea University in Sweden. The findings come in the context of newer, but much pricier, blood thinners – drugs such as Eliquis, Pradaxa and Xarelto. One expert who reviewed the new study said he would still opt for these medications over warfarin, because they are so much easier to manage. "In my opinion, the benefits of improved patient ... Read more

Related support groups: Aspirin, Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Pradaxa, Excedrin, Eliquis, Prevention of Thromboembolism in Atrial Fibrillation, Aggrenox, Alka-Seltzer, Fiorinal, Excedrin Migraine, Ecotrin, Fiorinal with Codeine, Arthritis Pain, Arthritis Pain Formula, Soma Compound, Bayer Aspirin, Norgesic

Many With Irregular Heartbeat Missing Out on Stroke-Preventing Treatments

Posted 16 Mar 2016 by Drugs.com

WEDNESDAY, March 16, 2016 – Doctors know that a heart rhythm disorder called atrial fibrillation increases the odds for stroke. But less than half of "a-fib" patients at highest risk for stroke are prescribed recommended blood thinners by their cardiologists, new research finds. "The findings of our study are surprising given that these patients with atrial fibrillation were treated by a cardiovascular specialist, who should be aware of guideline recommendations" for anticoagulants, such as warfarin, said study lead author Dr. Jonathan Hsu. He is a cardiologist and assistant professor of medicine at the University of California, San Diego. Hsu's team tracked more than 400,000 atrial fibrillation patients in the United States for four years. The investigators found that most were prescribed blood-thinning drugs up to a point. But more than 50 percent of the very highest-risk patients ... Read more

Related support groups: Warfarin, Coumadin, Atrial Fibrillation, Ischemic Stroke, Xarelto, Pradaxa, Eliquis, Transient Ischemic Attack, Prevention of Thromboembolism in Atrial Fibrillation, Rivaroxaban, Ischemic Stroke - Prophylaxis, Apixaban, Dabigatran, Jantoven, Reversal of Dabigatran

FDA Approves Praxbind (idarucizumab) as a Reversal Agent for the Anticoagulant Pradaxa

Posted 19 Oct 2015 by Drugs.com

October 16, 2015 – The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects. “The anticoagulant effects of Pradaxa are important and life-saving for some patients, but there are situations where reversal of the drug’s effects is medically necessary,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. “Today’s approval offers the medical community an important tool for managing patients taking Pradaxa in emergency or life-threatening situations when bleeding can’t be controlled.” The FDA approved Pradaxa in 2010 to prevent stroke and systemic blood clots in patients with atrial fibrillation, ... Read more

Related support groups: Pradaxa, Dabigatran, Praxbind, Reversal of Dabigatran, Idarucizumab

FDA Approves Praxbind to Reverse Blood Thinner's Effect

Posted 19 Oct 2015 by Drugs.com

FRIDAY, Oct. 16, 2015 – Emergency use of a drug to reverse the blood-thinning effects of another drug has been approved by the U.S. Food and Drug Administration. Praxbind (idarucizumab) was cleared for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's blood-thinning effects. "The anticoagulant effects of Pradaxa are important and lifesaving for some patients, but there are situations where reversal of the drug's effects is medically necessary," Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products at the FDA's Center for Drug Evaluation and Research, said in an FDA news release. "Today's approval offers the medical community an important tool for managing patients taking Pradaxa in emergency or life-threatening situations when bleeding can't be controlled," he added. Pradaxa is prescribed to ... Read more

Related support groups: Pradaxa, Praxbind, Reversal of Dabigatran

Ask a Question

Further Information

Related Condition Support Groups

Prevention of Thromboembolism in Atrial Fibrillation

Related Drug Support Groups

Praxbind, idarucizumab